Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
This study aimed to investigate the potential role of vitamin D in DSS-induced colitis, thereby providing novel insights into the clinical management of intestinal diseases.
Source: 1. Introduction. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Animal research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
After 1 week of adaptive feeding, the mice were randomly allocated into four groups with equal sample sizes (n = 5).
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Vitamin D Modified DSS-Induced Colitis in Mice via STING Signaling Pathway
Study design awaiting verification · Biology · 2025
Original publication title
Vitamin D Modified DSS-Induced Colitis in Mice via STING Signaling Pathway
© 2025 by the authors.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Simple Summary
Previous research has established a correlation between low levels of vitamin D and the severity of inflammatory bowel disease. Our study provides evidence that vitamin D supplementation significantly mitigated colitis induced by dextran sulfate sodium through the suppression of dysregulated immune responses, reduction in inflammation, and restoration of gut microbiota equilibrium. Mechanistically, vitamin D exerts its effects by inhibiting the activation of the GATA1/STING signaling pathway, which leads to a downregulation of type I interferon production and the release of inflammatory cytokines.
These actions are instrumental in maintaining the integrity of the intestinal barrier and alleviating gut dysbiosis, a characteristic feature of IBD. Vitamin D not only reduces pro-inflammatory cytokines but also promotes the proliferation of beneficial microbial communities, underscoring its dual role in immune regulation and microbiota homeostasis. In general, the modulation of the STING pathway by vitamin D indicates a potential novel therapeutic approach for the management of IBD.
Abstract
Although the underlying mechanisms are not yet fully understood, vitamin D has been proven to be associated with the pathogenesis of inflammatory bowel disease, participating in immune response and regulating gut microbiota composition. In this study, we established a dextran sodium sulfate-induced colitis model and intervened with vitamin D. Subsequently, colonic histopathology, serum biochemistry, transcription of inflammatory cytokines, gut microbiota, and key signaling pathways were examined. Our research demonstrated that intervention with vitamin D reduced the disease activity index of DSS-induced colitis and improved histopathological changes, protecting tight junction protein ZO-1 and intestinal glands from damage induced by DSS.
Analysis of gut microbiota revealed alterations in both α diversity and β diversity in DSS-induced colitis, whereas interventions with active vitamin D corrected the changes in certain bacterial abundance and improved the composition of gut microbiota. The transcription levels of inflammatory cytokines, including IL-23, IL-1β, IFN-γ, IL-6, IL-17, and STING, were elevated in the DSS-induced colitis model. However, intervention with active vitamin D effectively suppressed the transcription of these factors. Finally, immunohistochemistry and Western blotting revealed that the intervention with vitamin D suppressed the expression of proteins associated with the STING pathway, including GATA1, STING, IRF3, and IKBα, leading to inhibition of downstream IFN-β production.
Vitamin D administration can ameliorate the severity of DSS-induced colitis by preserving intestinal barrier integrity, modulating gut microbiota composition through suppression of the STING pathway.
Authors’ abstract
Simple Summary
Previous research has established a correlation between low levels of vitamin D and the severity of inflammatory bowel disease. Our study provides evidence that vitamin D supplementation significantly mitigated colitis induced by dextran sulfate sodium through the suppression of dysregulated immune responses, reduction in inflammation, and restoration of gut microbiota equilibrium. Mechanistically, vitamin D exerts its effects by inhibiting the activation of the GATA1/STING signaling pathway, which leads to a downregulation of type I interferon production and the release of inflammatory cytokines.
These actions are instrumental in maintaining the integrity of the intestinal barrier and alleviating gut dysbiosis, a characteristic feature of IBD. Vitamin D not only reduces pro-inflammatory cytokines but also promotes the proliferation of beneficial microbial communities, underscoring its dual role in immune regulation and microbiota homeostasis. In general, the modulation of the STING pathway by vitamin D indicates a potential novel therapeutic approach for the management of IBD.
Abstract
Although the underlying mechanisms are not yet fully understood, vitamin D has been proven to be associated with the pathogenesis of inflammatory bowel disease, participating in immune response and regulating gut microbiota composition. In this study, we established a dextran sodium sulfate-induced colitis model and intervened with vitamin D. Subsequently, colonic histopathology, serum biochemistry, transcription of inflammatory cytokines, gut microbiota, and key signaling pathways were examined. Our research demonstrated that intervention with vitamin D reduced the disease activity index of DSS-induced colitis and improved histopathological changes, protecting tight junction protein ZO-1 and intestinal glands from damage induced by DSS.
Analysis of gut microbiota revealed alterations in both α diversity and β diversity in DSS-induced colitis, whereas interventions with active vitamin D corrected the changes in certain bacterial abundance and improved the composition of gut microbiota. The transcription levels of inflammatory cytokines, including IL-23, IL-1β, IFN-γ, IL-6, IL-17, and STING, were elevated in the DSS-induced colitis model. However, intervention with active vitamin D effectively suppressed the transcription of these factors. Finally, immunohistochemistry and Western blotting revealed that the intervention with vitamin D suppressed the expression of proteins associated with the STING pathway, including GATA1, STING, IRF3, and IKBα, leading to inhibition of downstream IFN-β production.
Vitamin D administration can ameliorate the severity of DSS-induced colitis by preserving intestinal barrier integrity, modulating gut microbiota composition through suppression of the STING pathway.
Publication and source details
Original title: Vitamin D Modified DSS-Induced Colitis in Mice via STING Signaling Pathway
Zhihao Wu; Baohua Ma; Min Xiao; Qian Ren; Yanhua Shen; Zhengyu Zhou
Biology · 2025
* Correspondence: zacharyzhou@suda.edu.cn; Tel.: +86-0512-65880708These authors contributed equally to this work.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T01:45:32.851722+00:00
DOI: 10.3390/biology14060715 · PMC12190092